Meeting
2022 ASCO Annual Meeting
Prevalence of ocular comorbidities in patients with multiple myeloma: An analysis of U.S. claims data.
Presenter
Sikander Ailawadhi, MD
Mayo Clinic
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8038)
DOI
10.1200/JCO.2022.40.16_suppl.8038
Abstract #
8038
Poster Bd #
462
Abstract Disclosures
Similar Videos & Slides
Speaker: Panel Discussion
Videos & Slides
2024 ASCO Annual Meeting
Final results of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous stem cell transplant (AuSCT) in patients (Pts) with multiple myeloma (MM).
Speaker: Sheeba K. Thomas, MD
Videos & Slides
2024 ASCO Annual Meeting
Assessing the prognostic value of transcriptomic data in multiple myeloma through machine learning methodologies.
Speaker: Majid Jaberi-Douraki, Ph.D
Speaker: Sham Mailankody, MBBS